Gilead Beats Earnings Estimates on Strong HIV Sales. The Stock Is Rising.
Gilead Sciences has battled back from a pipeline disappointment last year to its highest stock price in nearly a decade.
Gilead provides upbeat 2025 forecast, shares rise 4%
Gilead Sciences posted fourth-quarter results that exceeded Wall Street estimates on Tuesday as its HIV drug sales rose 16% ...
STAT1d
Gilead’s short-term win threatens the future of pharmaceutical public-private partnerships
The settlement in U.S. v. Gilead could disturb the model of public-private partnership that sustains many of the United ...
How key drugs boosted Gilead — and how the Inflation Reduction Act could deliver a billion-dollar hit
Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...
Gilead Sciences (NASDAQ:GILD) Hits New 12-Month High on Earnings Beat
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Wednesday following a better than expected earnings announcement. The company ...
FiercePharma1d
Gilead, riding high from HIV sales boost, charts course for long-acting PrEP launch
With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market ...
Gilead price target raised to $116 from $109 at BofA
BofA raised the firm’s price target on Gilead (GILD) to $116 from $109 and keeps a Buy rating on the shares. Q4 results “handily beat ...
‘The Handmaid’s Tale’ Reveals Final Season Release Date and First Look: The Red Revolution Is Here
The red-cloaked army is coming for Gilead in a the first look at the Hulu hit's April return. The Handmaid’s Tale has revealed its release date and a first-look teaser for the highly anticipated final ...
These Stocks Are Moving the Most Today: Super Micro, Tesla, CVS, Vertiv, Zillow, Upstart, Lyft, Gilead, and More
Super Micro Computer rises after issuing strong guidance for fiscal 2026, Tesla shares extend losses into a sixth day, and ...
Gilead upgraded to Buy from Hold at DZ Bank
DZ Bank upgraded Gilead (GILD) to Buy from Hold with a $108 price target Maximize Your Portfolio with Data Driven Insights:Leverage the power ...
‘The Handmaid’s Tale’ Sequel ‘The Testaments’ Finds Its Star
Chase Infiniti joins Ann Dowd in Hulu's next Margaret Atwood adaptation, continuing the story within the Gilead universe.